tiprankstipranks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market
RAD
Radiopharm Theranostics Limited
RESEARCH TOOLSreports
Want to see AU:RAD full AI Analyst Report?

Radiopharm Theranostics Limited (RAD) Stock News & Sentiment

24 Followers
Radiopharm Theranostics reshapes finance and governance team under Acclime partnership
Premium
Company Announcements
Radiopharm Theranostics reshapes finance and governance team under Acclime partnership
3d ago
RAD
Radiopharm Theranostics advances radiopharmaceutical pipeline with key trial milestones
Premium
Company Announcements
Radiopharm Theranostics advances radiopharmaceutical pipeline with key trial milestones
11d ago
RAD
Radiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
Premium
Company Announcements
Radiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
14d ago
RAD
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
Premium
Company Announcements
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
18d ago
RAD
Radiopharm Director Adjusts Share and Option Holdings
Premium
Company Announcements
Radiopharm Director Adjusts Share and Option Holdings
1M ago
RAD
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
Premium
Ratings
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
1M ago
RADX
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
Premium
Company Announcements
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
1M ago
RAD
More AU:RAD News >

RAD News on the Web

Health Check: Local cancer drug developers put their best foot forward globally
StockHead
Neutral
Radiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
TipRanks News
Bullish
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
TipRanks News
Neutral
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
TipRanks News
Bullish
Health Check: US military top brass warms to Aussie blood platelet freezing method
StockHead
Neutral
Radiopharm Director Adjusts Share and Option Holdings
TipRanks News
Neutral
Inside Biotech: Radiopharm advances RAD 402 into clinic with first patient dosed in Phase 1 trial
Proactive Investors
Bullish
Radiopharm advances RAD 402 into clinic with first patient dosed in Phase 1 trial
Proactive Investors
Bullish

News Score - Last 7 Days

Positive
AU:RAD
Sector Average
Media Buzz
This Week3 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:RAD’s Media Buzz Sentiment?
3 articles about AU:RAD were published this week. In an average week, 3 articles are published.
    What is AU:RAD’s weekly average amount of articles?
    In an average week, 3 articles about AU:RAD are published.
      What is AU:RAD’s News Sentiment?
      100% of articles about AU:RAD were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week